Position in RPRX
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$898,765
+$120,788 QoQ
Shares Held
18,736
-6.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kestra Advisory Services, LLC holds $25,439,677 across 48 Biotechnology names. RPRX ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,950 | $6,229,233 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,470 | $3,453,700 | |
| 3 | CELC |
Celcuity Inc.
|
13,604 | $1,552,760 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
21,052 | $1,001,443 | |
| 5 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
39,901 | $987,948 | |
| 6 | RPRX |
Royalty Pharma plc
This page
|
18,736 | $898,765 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
27,122 | $882,549 | |
| 8 | CING |
Cingulate Inc.
|
140,000 | $869,400 |
All Filings in RPRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $898,765 | 18,736 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $777,977 | 20,134 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $727,896 | 20,632 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $767,475 | 21,301 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $662,228 | 21,273 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $551,271 | 21,610 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||